natalizumab,ocrelizumab
roche,biogen
['ocrelizumab', 'natalizumab']
dra. van kempen. eid of natalizumab is as effective as 4wk interval. we've already known but is important to remember it. personal note: it's not reduce pml risk.
we'll see if extend ocrelizumab is effective. #ectrims2022
#Neurólogo #EsclerosisMúltiple. Crítico con la salud, la clase médica y, sobre todo, con mi especialidad. Digo cosas que no gustan. El trombo que lo saque otro.